{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:01:00Z","timestamp":1793815260749,"version":"4.6.1"},"reference-count":82,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health, Italy","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Stroke is one of the leading causes of death and disability worldwide, so there is an urgent need to find a therapy for the tragic outcomes of this cerebrovascular disease. Stem cells appeared to be a good solution for many conditions, so different experiments were made to establish stem cells as a feasible therapy for stroke. The aim of this review is to analyze the state of the art of stem cell therapy for stroke and if the route of administration could represent a valid adjusting point for ameliorating the therapy\u2019s outcome. To obtain this, we searched the scientific literature of the last 10 years for relevant in vitro and in vivo evidence regarding stem cells\u2019 potential in stroke therapy. In vitro evidence points to hypoxia, among the preconditioning strategies, as the most used and probably efficient method to enhance cells qualities, while in vivo results raise the question if it is the type of cells or how they are administrated which can make the difference in terms of efficiency. Unfortunately, despite the number of clinical trials, only a few were successfully concluded, demonstrating how urgent the necessity is to translate pre-clinical results into clinics. Since any type of stem cell seems suitable for therapy, the chosen route of administration corresponds to different engraftment rates, distribution and efficiency in terms of the beneficial effects of stem cells. Intravenous administration was widely used for delivering stem cells into the human body, but recently intranasal administration has given promising results in vivo. It allows stem cells to efficiently reach the brain that was precluded to intravenous administration, so it is worth further investigation.<\/jats:p>","DOI":"10.3390\/bioengineering10010118","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T01:31:15Z","timestamp":1673832675000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don\u2019t We Focus on Their Administration?"],"prefix":"10.3390","volume":"10","author":[{"given":"Andrea","family":"Valeri","sequence":"first","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"key":"ref_1","unstructured":"American Association of Neurological Surgeon (2022, October 26). Cerebrovascular Disease. Available online: https:\/\/www.aans.org\/en\/Patients\/Neurosurgical-Conditions-and-Treatments\/Cerebrovascular-Disease."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.stem.2007.05.013","article-title":"On the Origin of the Term \u201cStem Cell\u201d","volume":"1","author":"Willenbring","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/sci-2020-001","article-title":"Current state of stem cell-based therapies: An overview","volume":"7","author":"Aly","year":"2020","journal-title":"Stem Cell Investig."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_5","unstructured":"(2022, October 26). National Heart, Lung and Blood Institute. What Is a Stroke?, Available online: https:\/\/www.nhlbi.nih.gov\/health\/stroke."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"l6983","DOI":"10.1136\/bmj.l6983","article-title":"Management of acute ischemic stroke","volume":"368","author":"Phipps","year":"2020","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1747-4949.2012.00839.x","article-title":"Pathophysiologic Cascades in Ischemic Stroke","volume":"7","author":"Xing","year":"2012","journal-title":"Int. J. Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The Role of Oxidative Stress in Neurodegenerative Diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.jcbfm.9600495","article-title":"Proliferating resident microglia after focal cerebral ischaemia in mice","volume":"27","author":"Denes","year":"2007","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/glia.440070117","article-title":"Cytotoxicity of microglia","volume":"7","author":"Banati","year":"1993","journal-title":"Glia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/STROKEAHA.110.596718","article-title":"Molecular pathophysiology of cerebral hemorrhage: Secondary brain injury","volume":"42","author":"Aronowski","year":"2011","journal-title":"Stroke"},{"key":"ref_13","unstructured":"(2022, October 26). US Department of Health and Human Services. What Are Some Common Outcomes of Stroke & Some Common Treatments for These Outcomes?, Available online: https:\/\/www.nichd.nih.gov\/health\/topics\/stroke\/conditioninfo\/treatment#."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08998280.2011.11928729","article-title":"Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke","volume":"24","author":"Roth","year":"2011","journal-title":"Proc. (Bayl. University. Med. Cent.)"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"582605","DOI":"10.3389\/fneur.2020.582605","article-title":"The Next Step in the Treatment of Stroke","volume":"11","author":"Matei","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"633781","DOI":"10.3389\/fneur.2021.633781","article-title":"Is Fluoxetine Good for Subacute Stroke? A Meta-Analysis Evidenced From Randomized Controlled Trials","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/STROKEAHA.120.033231","article-title":"Advances in Stroke: Therapies Targeting Stroke Recovery","volume":"52","author":"Richards","year":"2021","journal-title":"Stroke"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nbd.2009.10.003","article-title":"Optimizing the success of cell transplantation therapy for stroke","volume":"37","author":"Bliss","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fnins.2020.00473","article-title":"Application of Stem Cells in Stroke: A Multifactorial Approach","volume":"14","author":"Singh","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1048113","DOI":"10.3389\/fneur.2022.1048113","article-title":"Mesenchymal stem cell therapy for ischemic stroke: Novel insight into the crosstalk with immune cells","volume":"13","author":"Tan","year":"2022","journal-title":"Front Neurol"},{"key":"ref_23","first-page":"6","article-title":"Multipotent Stem Cell and Current Application","volume":"55","author":"Sobhani","year":"2017","journal-title":"Acta Med. Iran."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1532-950X.2005.00063.x","article-title":"Stem Cells: Classifications, Controversies, and Clinical Applications","volume":"34","author":"Fortier","year":"2005","journal-title":"Vet. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.cellbio.17.1.435","article-title":"Embryo-derived stem cells: Of mice and men","volume":"17","author":"Smith","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/cr.2009.24","article-title":"Tissue-specific stem cells: Friend or foe?","volume":"19","author":"Huelsken","year":"2009","journal-title":"Cell Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.tice.2020.101351","article-title":"Umbilical cord stem cells: Background, processing and applications","volume":"65","author":"Alatyyat","year":"2020","journal-title":"Tissue Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6940283","DOI":"10.1155\/2016\/6940283","article-title":"Stem Cells Applications in Regenerative Medicine and Disease Therapeutics","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zayed, M.A., Sultan, S., Alsaab, H.O., Yousof, S.M., Alrefaei, G.I., Alsubhi, N.H., Alkarim, S., Al Ghamdi, K.S., Bagabir, S.A., and Jana, A. (2022). Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders. Cells, 11.","DOI":"10.3390\/cells11213476"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/WNR.0000000000001828","article-title":"Enhancing oxidative phosphorylation over glycolysis for energy production in cultured mesenchymal stem cells","volume":"33","author":"Monsour","year":"2022","journal-title":"Neuroreport"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gorsky, A., Monsour, M., Nguyen, H., Castelli, V., Lee, J.Y., and Borlongan, C.V. (2022). Metabolic Switching of Cultured Mesenchymal Stem Cells Creates Super Mitochondria in Rescuing Ischemic Neurons. Neuromol. Med.","DOI":"10.1007\/s12017-022-08720-3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101482","DOI":"10.1016\/j.tice.2020.101482","article-title":"Interleukin-17A promotes the differentiation of bone marrow mesenchymal stem cells into neuronal cells","volume":"69","author":"Chen","year":"2021","journal-title":"Tissue Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0963689717720291","article-title":"Hypoxic Culture Promotes Dopaminergic-Neuronal Differentiation of Nasal Olfactory Mucosa Mesenchymal Stem Cells via Upregulation of Hypoxia-Inducible Factor-1\u03b1","volume":"26","author":"Zhuo","year":"2017","journal-title":"Cell Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1089\/scd.2020.0031","article-title":"Ischemia-Induced Multipotent Stem Cells Isolated from Stroke Patients Exhibit Higher Neurogenic Differentiation Potential than Bone Marrow-Derived Mesenchymal Stem Cells","volume":"29","author":"Rajbhandari","year":"2020","journal-title":"Stem Cells Dev."},{"key":"ref_39","first-page":"e2761","article-title":"Mouse model of middle cerebral artery occlusion","volume":"48","author":"Chiang","year":"2011","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106678","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106678","article-title":"Involvement of T-bet and GATA3 transcription factors in Mesenchymal stem cells and royal jelly combination treatment in brain stroke","volume":"31","author":"Rahmani","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/nprot.2006.450","article-title":"Stereotaxic gene delivery in the rodent brain","volume":"1","author":"Cetin","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12975-016-0482-6","article-title":"Stem Cell Therapy and Administration Routes After Stroke","volume":"7","author":"Fuentes","year":"2016","journal-title":"Transl. Stroke Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: A phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jnnp-2019-322515","article-title":"Intracerebral implantation of human neural stem cells and motor recovery after stroke: Multicentre prospective single-arm study (PISCES-2)","volume":"91","author":"Muir","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/cns.13890","article-title":"Transplantation of Roxadustat-preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats","volume":"28","author":"Chen","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wang, Z., Cai, Y., Zhang, Q., Li, J., Lin, B., Zhao, J., Zhang, F., Li, Y., Yang, X., and Lu, L. (2022). Upregulating HIF-1\u03b1 to Boost the Survival of Neural Stem Cells via Functional Peptides-Complexed MRI-Visible Nanomedicine for Stroke Therapy. Adv. Healthc. Mater., e2201630.","DOI":"10.1002\/adhm.202201630"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/cell.2022.0037","article-title":"Preconditioning with Trehalose Protects the Bone Marrow-Derived Mesenchymal Stem Cells Under Oxidative Stress and Enhances the Stem Cell-Based Therapy for Cerebral Ischemic Stroke","volume":"24","author":"Shu","year":"2022","journal-title":"Cell. Reprogramming"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"917181","DOI":"10.3389\/fncel.2022.917181","article-title":"Targeting 17\u03b2-estradiol biosynthesis in neural stem cells improves stroke outcome","volume":"16","author":"Patkar","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"114177","DOI":"10.1016\/j.expneurol.2022.114177","article-title":"Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain","volume":"357","author":"McCrary","year":"2022","journal-title":"Exp. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"106748","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106748","article-title":"Bone marrow-derived mesenchymal stem cells overexpressed with miR-182-5p protects against brain injury in a mouse model of cerebral ischemia","volume":"31","author":"Deng","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"113234","DOI":"10.1016\/j.biopha.2022.113234","article-title":"Dental pulp stem cell transplantation facilitates neuronal neuroprotection following cerebral ischemic stroke","volume":"152","author":"Gong","year":"2022","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","article-title":"Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution","volume":"108","author":"Barbash","year":"2003","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15283\/ijsc.2008.1.1.1","article-title":"Mesenchymal stem cell delivery routes and fate","volume":"1","author":"Kurtz","year":"2008","journal-title":"Int. J. Stem Cells"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"F315","DOI":"10.1152\/ajprenal.00098.2008","article-title":"Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury","volume":"295","author":"Yang","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/STROKEAHA.117.018288","article-title":"Intra-Arterial Delivery of Cell Therapies for Stroke","volume":"49","author":"Guzman","year":"2018","journal-title":"Stroke"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuroscience.2010.11.054","article-title":"Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats","volume":"175","author":"Merino","year":"2011","journal-title":"Neuroscience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8889061","DOI":"10.1155\/2020\/8889061","article-title":"Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?","volume":"2020","author":"Chia","year":"2020","journal-title":"Stem Cells Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11234","DOI":"10.18632\/aging.202807","article-title":"Ischemic-hypoxic preconditioning enhances the mitochondrial function recovery of transplanted olfactory mucosa mesenchymal stem cells via miR-181a signaling in ischemic stroke","volume":"13","author":"Zhuo","year":"2021","journal-title":"Aging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4252\/wjsc.v13.i12.1905","article-title":"Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats","volume":"13","author":"Zhao","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Li, T., Sun, Q., Feng, L., Yan, D., Wang, B., Li, M., Xiong, X., Ma, D., and Gao, Y. (2022). Uncovering the characteristics of the gut microbiota in patients with acute ischemic stroke and phlegm-heat syndrome. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276598"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4805040","DOI":"10.1155\/2021\/4805040","article-title":"OM-MSCs Alleviate the Golgi Apparatus Stress Response following Cerebral Ischemia\/Reperfusion Injury via the PEDF-PI3K\/Akt\/mTOR Signaling Pathway","volume":"2021","author":"He","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Schmidt, R.F., and Willis, W.D. (2007). Intracerebroventricular, Intracerebral and Intrathecal. Encyclopedia of Pain, Springer.","DOI":"10.1007\/978-3-540-29805-2_2022"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13287-022-03189-0","article-title":"Mesenchymal stem cell aggregation mediated by integrin \u03b14\/VCAM-1 after intrathecal transplantation in MCAO rats","volume":"13","author":"Ran","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/stcltm\/szac062","article-title":"Tanshinone IIA-Loaded Nanoparticle and Neural Stem Cell Therapy Enhances Recovery in a Pig Ischemic Stroke Model","volume":"11","author":"Kaiser","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.intimp.2013.07.016","article-title":"Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)","volume":"17","author":"Yousefi","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"114001","DOI":"10.1016\/j.bbr.2022.114001","article-title":"Adipose-derived mesenchymal stem cells reduced transient cerebral ischemia injury by modulation of inflammatory factors and AMPK signaling","volume":"433","author":"Ranjbaran","year":"2022","journal-title":"Behav. Brain Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/stem.3426","article-title":"Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme-2 and masR receptor-dependent","volume":"39","author":"Barzegar","year":"2021","journal-title":"Stem Cells (Dayt. Ohio)"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.braindev.2014.06.010","article-title":"Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia","volume":"37","author":"Ohshima","year":"2015","journal-title":"Brain Dev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"ref_71","first-page":"419","article-title":"Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage","volume":"68","author":"Kavelaars","year":"2010","journal-title":"Pediatr. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Mousavi, S.M., Akbarpour, B., Karimi-Haghighi, S., Pandamooz, S., Bel\u00e9m-Filho, I.J.A., Mas\u00eds-Calvo, M., Salimi, H., Lashanizadegan, R., Pouramini, A., and Owjfard, M. (2022). Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke. BMC Neurosci., 23.","DOI":"10.1186\/s12868-022-00732-w"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/NDT.S350586","article-title":"Optimization of an Intranasal Route for the Delivery of Human Neural Stem Cells to Treat a Neonatal Hypoxic-Ischemic Brain Injury Rat Model","volume":"18","author":"Lu","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"113542","DOI":"10.1016\/j.expneurol.2020.113542","article-title":"Combinatorial intranasal delivery of bone marrow mesenchymal stem cells and insulin-like growth factor-1 improves neurovascularization and functional outcomes following focal cerebral ischemia in mice","volume":"337","author":"Shen","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/STROKEAHA.120.031191","article-title":"Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke","volume":"52","author":"Larpthaveesarp","year":"2021","journal-title":"Stroke"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Chau, M.J., Deveau, T.C., Gu, X., Kim, Y.S., Xu, Y., Yu, S.P., and Wei, L. (2018). Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice. BMC Neurosci., 19.","DOI":"10.1186\/s12868-018-0418-z"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/jnr.23954","article-title":"Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats","volume":"95","author":"Dzietko","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_78","unstructured":"Preedy, V.R. (2019). Chapter 15\u2014Effects of Alcohol on the Corpus Callosum. Neuroscience of Alcohol, Academic Press."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.expneurol.2015.03.011","article-title":"Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice","volume":"272","author":"Sun","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","article-title":"Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): A first-in-human, open-label intervention study","volume":"21","author":"Baak","year":"2022","journal-title":"Lancet. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5853\/jos.2016.01263","article-title":"Adult Stem Cell Therapy for Stroke: Challenges and Progress","volume":"18","author":"Bang","year":"2016","journal-title":"J. Stroke"}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/10\/1\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:24Z","timestamp":1760119584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/10\/1\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["bioengineering10010118"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering10010118","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]}}}